|
1
|
Wen N, Cai Y, Li F, Ye H, Tang W, Song P
and Cheng N: The clinical management of hepatocellular carcinoma
worldwide: A concise review and comparison of current guidelines:
2022 update. Biosci Trends. 16:20–30. 2022. View Article : Google Scholar
|
|
2
|
Guo ST, Chi MN, Yang RH, Guo XY, Zan LK,
Wang CY, Xi YF, Jin L, Croft A, Tseng HY, et al: INPP4B is an
oncogenic regulator in human colon cancer. Oncogene. 35:3049–3061.
2016. View Article : Google Scholar
|
|
3
|
Coriat R, Mir O, Cessot A, Brezault C,
Ropert S, Durand JP, Cacheux W, Chaussade S and Goldwasser F:
Feasibility of oxaliplatin, 5-fluorouracil and leucovorin
(FOLFOX-4) in cirrhotic or liver transplant patients: Experience in
a cohort of advanced hepatocellular carcinoma patients. Invest New
Drugs. 30:376–381. 2012. View Article : Google Scholar
|
|
4
|
Petrelli F, Coinu A, Borgonovo K, Cabiddu
M, Ghilardi M, Lonati V and Barni S: Oxaliplatin-based
chemotherapy: A new option in advanced hepatocellular carcinoma. a
systematic review and pooled analysis. Clin Oncol (R Coll Radiol).
26:488–496. 2014. View Article : Google Scholar
|
|
5
|
Massarweh NN and El-Serag HB: Epidemiology
of hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Cancer Control. 24:10732748177292452017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhong Q, Li M and Shangguan X:
Retrospective analysis of oxaliplatin adverse reactions/events
based on database. Med Herald. 39:239–243. 2020.In Chinese.
|
|
7
|
Wang H, Xu L and Zhao L: Literature
analysis of 126 cases of oxaliplatin adverse reactions.
Pharmacovigilance China. 16:110–114. 2019.In Chinese.
|
|
8
|
Yu W, Zhang X and Huang Q: Protective
Effect and Mechanism of Resveratrol on Peripheral Nerve Toxicity
Induced by Oxaliplatin in Rats. Trad Chin Drug Res Clin Pharm.
30:20–25. 2019.In Chinese.
|
|
9
|
Liu XW, Lou YN and Feng Z: Research status
on efficacy enhancement and toxicity reduction of Chinese medicine
in treatment of malignant tumors:a review of projects supported by
National Natural Science Foundation of China. China J Chinese
Materia Medica. 47:253–258. 2022.In Chinese.
|
|
10
|
Wei Q, Li P, Yang T, Zhu J, Sun L, Zhang
Z, Wang L, Tian X, Chen J, Hu C, et al: The promise and challenges
of combination therapies with antibody-drug conjugates in solid
tumors. J Hematol Oncol. 17:12024. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Feng Y, An Q, Zhao Z, Wu M, Yang C, Liang
W, Xu X, Jiang T and Zhang G: Beta-elemene: A phytochemical with
promise as a drug candidate for tumor therapy and adjuvant tumor
therapy. Biomed Pharmacother. 172:1162662024. View Article : Google Scholar
|
|
12
|
Liu H, Deng R, Zhu CW, Han HK, Zong GF,
Ren L, Cheng P, Wei ZH, Zhao Y, Yu SY and Lu Y: Rosmarinic acid in
combination with ginsenoside Rg1 suppresses colon cancer metastasis
via co-inhition of COX-2 and PD1/PD-L1 signaling axis. Acta
Pharmacol Sin. 45:193–208. 2024. View Article : Google Scholar
|
|
13
|
Gou B, Chen G, Huang S, Ning N, Gu Q, Duan
S, Du Y, Nan Y and Yuan L: Review: Performance of jujube and its
extracts in cancer: Therapeutic, toxicity-reducing and potentiating
effects. Front Oncol. 15:14899742025. View Article : Google Scholar
|
|
14
|
Li J, Fan S, Li H, Hu ZP and Hu Q:
Evaluation of efficacy, safety and underlying mechanism on
Traditional Chinese medicine as synergistic agents for cancer
immunotherapy: A preclinical systematic review and meta-analysis. J
Ethnopharmacol. 338(Pt 1): 1190352025. View Article : Google Scholar
|
|
15
|
Gao Q, Sheng Q, Yang Z, Zhu Z, Li L, Xu L,
Xia J, Qiao Y, Gu J, Zhu X, et al: Honokiol-Magnolol-Baicalin
Possesses synergistic anticancer potential and enhances the
efficacy of Anti-PD-1 immunotherapy in colorectal cancer by
triggering GSDME-dependent pyroptosis. Adv Sci (Weinh).
12:e24170222025. View Article : Google Scholar
|
|
16
|
Sidhu H and Capalash N: Synergistic
anti-cancer action of salicylic acid and cisplatin on HeLa cells
elucidated by network pharmacology and in vitro analysis. Life Sci.
282:1198022021. View Article : Google Scholar
|
|
17
|
Chen L: Efficacy and mechanism of
sorafenib combined with coix seed oil in the treatment of
hepatocellular carcinoma. Lanzhou University; Lanzhou: 2018
|
|
18
|
Sui J, Li F and Guo Y: Research progress
on chemical constituents and pharmacological effects of Herba
Cistanches and its predictive analysis of quality markers. J
Liaoning Univ Trad Chin Med. 23:191–196. 2021.In Chinese.
|
|
19
|
You S, Zhao J and Ma L: The effect and
mechanism of ethanol extract of Herba Cistanches on immune hepatic
fibrosis in rats. Chin J Pharm Toxicol. 30:504–510. 2016.In
Chinese.
|
|
20
|
Zhang A, Yang X, Li Q, Yang Y, Zhao G,
Wang B and Wu D: Immunostimulatory activity of water-extractable
polysaccharides from Cistanche deserticola as a plant adjuvant in
vitro and in vivo. PLoS One. 13:e01913562018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guo Y, Meng S and Li Y: The effects of
tonifying kidney and activating blood method adjuvant oxaliplatin
in the treatment of gastrointestinal tumors. Med J Chin People
Armed Police Forces. 31:707–710. 2020.In Chinese.
|
|
22
|
Wen L, Hu J, Zhang J and Yang J:
Phenylethanol glycosides from Herba Cistanche improve the hypoxic
tumor microenvironment and enhance the effects of oxaliplatin via
the HIF-1α signaling pathway. Mol Med Rep. 24:5172021. View Article : Google Scholar
|
|
23
|
Hei B, Wang J, Wu G, Ouyang J and Liu RE:
Verbascoside suppresses the migration and invasion of human
glioblastoma cells via targeting c-Met-mediated
epithelial-mesenchymal transition. Biochem Biophys Res Commun.
514:1270–1277. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jia WQ, Zhu JW, Yang CY, Ma J, Pu TY, Han
GQ, Zou MM and Xu RX: Verbascoside inhibits progression of
glioblastoma cells by promoting Let-7g-5p and down-regulating HMGA2
via Wnt/beta-catenin signalling blockade. J Cell Mol Med.
24:2901–2916. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wei M, Cao L and Hui L: Research progress
on anti-tumor mechanism of verbascoside. Guiding J Trad Chin Med
Pharm. 26:125–128. 2020.In Chinese.
|
|
26
|
Khan RA, Hossain R, Roy P, Jain D,
Mohammad Saikat AS, Roy Shuvo AP, Akram M, Elbossaty WF, Khan IN,
Painuli S, et al: Anticancer effects of acteoside: Mechanistic
insights and therapeutic status. Eur J Pharmacol. 916:1746992022.
View Article : Google Scholar
|
|
27
|
Xiao Y, Ren Q and Wu L: The
pharmacokinetic property and pharmacological activity of acteoside:
A review. Biomed Pharmacother. 153:1132962022. View Article : Google Scholar
|
|
28
|
Peerzada KJ, Faridi AH, Sharma L, Bhardwaj
SC, Satti NK, Shashi B and Tasduq SA: Acteoside-mediates
chemoprevention of experimental liver carcinogenesis through STAT-3
regulated oxidative stress and apoptosis. Environ Toxicol.
31:782–798. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhu B: Experimental study on the effect of
verbascoside on the proliferation and autophagy of hepatocellular
carcinoma cells through JNK signaling pathway. Lanzhou University;
Lanzhou: 2020
|
|
30
|
Mou JF, Lin XZ, Su HL, Lu HL, Liu QB,
Liang B, Chen X, Liang CQ and Zhou XL: Anti-hepatitis B virus
activity and hepatoprotective effect of des(rhamnosyl) verbascoside
from Lindernia ruellioides in vitro. Phytother Res. 35:4555–4566.
2021. View Article : Google Scholar
|
|
31
|
Lee KJ, Woo ER, Choi CY, Shin DW, Lee DG,
You HJ and Jeong HG: Protective effect of acteoside on carbon
tetrachloride-induced hepatotoxicity. Life Sci. 74:1051–1064. 2004.
View Article : Google Scholar
|
|
32
|
Chou TC: Theoretical basis, experimental
design, and computerized simulation of synergism and antagonism in
drug combination studies. Pharmacol Rev. 58:621–681. 2006.
View Article : Google Scholar
|
|
33
|
Qin Y, Liu HJ, Li M, Zhai DH, Tang YH,
Yang L, Qiao KL, Yang JH, Zhong WL, Zhang Q, et al: Salidroside
improves the hypoxic tumor microenvironment and reverses the drug
resistance of platinum drugs via HIF-1alpha signaling pathway.
EBioMedicine. 38:25–36. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ge SX, Son EW and Yao R: iDEP: An
integrated web application for differential expression and pathway
analysis of RNA-Seq data. BMC bioinformatics. 19:5342018.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Moreno-Torres M, García-Llorens G, Moro E,
Méndez R, Quintás G and Castell JV: Factors that influence the
quality of metabolomics data in in vitro cell toxicity studies: A
systematic survey. Sci Rep. 11:221192021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li G, Zhao CY, Wu Q, Guan SY, Jin HW, Na
XL and Zhang YB: Integrated metabolomics and transcriptomics reveal
di(2-ethylhexyl) phthalate-induced mitochondrial dysfunction and
glucose metabolism disorder through oxidative stress in rat liver.
Ecotoxicol Environ Saf. 228:1129882021. View Article : Google Scholar
|
|
37
|
Luchtel RA, Bhagat T, Pradhan K, Jacobs WR
Jr, Levine M, Verma A and Shenoy N: High-dose ascorbic acid
synergizes with anti-PD1 in a lymphoma mouse model. Proc Natl Acad
Sci USA. 117:1666–1677. 2020. View Article : Google Scholar
|
|
38
|
Yang H, Lee HJ, Lee YG, Kim JW and Kim YS:
Integrity of the untorn articular-sided tendon in bursal-sided
partial-thickness rotator cuff tear: A comparative study of
apoptotic activity in torn and untorn layers. Am J Sports Med.
46:2478–2485. 2018. View Article : Google Scholar
|
|
39
|
Juríková M, Danihel Ľ, Polák Š and Varga
I: Ki67, PCNA, and MCM proteins: Markers of proliferation in the
diagnosis of breast cancer. Acta Histochem. 118:544–552. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jia WQ, Wang ZT, Zou MM, Lin JH, Li YH,
Zhang L and Xu RX: Verbascoside inhibits glioblastoma cell
proliferation, migration and invasion while promoting apoptosis
through upregulation of protein tyrosine phosphatase SHP-1 and
inhibition of STAT3 phosphorylation. Cell Physiol Biochem.
47:1871–1882. 2018. View Article : Google Scholar
|
|
41
|
Zhang Y, Yuan Y, Wu H, Xie Z, Wu Y, Song
X, Wang J, Shu W, Xu J, Liu B, et al: Effect of verbascoside on
apoptosis and metastasis in human oral squamous cell carcinoma. Int
J Cancer. 143:980–991. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen WS: The diagnostic values of Ki-67
and Ezrin protein in the pathology of primary liver cancer. Jilin
Med J. 2:2020.In Chinese.
|
|
43
|
Pan LC, Xiao HY, Yin WJ and Lin Z:
Correlation between HSD17B4 expression in rat liver cancer tissues
and inflammation or proliferation. Eur Rev Med Pharmacol Sci.
22:3386–3393. 2018.
|
|
44
|
Wu WY, Yang Z and Long FX: Effects of
Gehua Jieyu Recipe on GST-Pi and PCNA expressions and Wnt/β-catenin
signaling pathway in precancerous lesions of ethanol-induced HBV
transgenic mice. Chin J Immunol. 36:36–41. 2020.In Chinese.
|
|
45
|
Ye Z, Gao X, Zhao B, Li H, Wan M, Wu N,
Chang M and Cheng S: Diwu Yanggan capsule inhibits the occurrence
and development of liver cancer in the Solt-Farber rat model by
regulating the Ras/Raf/Mek/Erk signaling pathway. Am J Transl Res.
10:3797–3805. 2018.
|
|
46
|
Zhang JJ, Wang XP and Yang XY: Promoting
effects of BANCR on the proliferation, invasion and angiogenesis of
HepG2 hepatocellular carcinoma cells. Chin J Immunol. 34:25–30.
2018.In Chinese.
|
|
47
|
Kang L, Tian Y, Xu S and Chen H:
Oxaliplatin-induced peripheral neuropathy: Clinical features,
mechanisms, prevention and treatment. J Neurol. 268:3269–3282.
2021. View Article : Google Scholar
|
|
48
|
Hashemzadeh A, Amerizadeh F, Asgharzadeh
F, Darroudi M, Avan A, Hassanian SM, Landarani M and Khazaei M:
Delivery of oxaliplatin to colorectal cancer cells by
folate-targeted UiO-66-NH(2). Toxicol Appl Pharmacol.
423:1155732021. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Oun R, Moussa YE and Wheate NJ: The side
effects of platinum-based chemotherapy drugs: A review for
chemists. Dalton Trans. 47:6645–6653. 2018. View Article : Google Scholar
|
|
50
|
Kobuchi S, Katsuyama Y and Ito Y:
Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling
and simulation of oxaliplatin for hematological toxicity in rats.
Xenobiotica. 50:223–230. 2020. View Article : Google Scholar
|
|
51
|
Lees JG, White D, Keating BA, Barkl-Luke
ME, Makker PGS, Goldstein D and Moalem-Taylor G:
Oxaliplatin-induced haematological toxicity and splenomegaly in
mice. PLoS One. 15:e02381642020. View Article : Google Scholar :
|
|
52
|
Campo G, Pavasini R, Biscaglia S, Ferri A,
Andrenacci E, Tebaldi M and Ferrari R: Platelet aggregation values
in patients with cardiovascular risk factors are reduced by
verbascoside treatment. A randomized study. Pharmacol Res. 97:1–6.
2015. View Article : Google Scholar
|
|
53
|
Wu M, Yu S, Chen Y, Meng W, Chen H, He J,
Shen J and Lin X: Acteoside promotes B cell-derived IL-10
production and ameliorates autoimmunity. J Leukoc Biol.
112:875–885. 2022. View Article : Google Scholar
|
|
54
|
Falcone A, Ricci S, Brunetti I, Pfanner E,
Allegrini G, Barbara C, Crinò L, Benedetti G, Evangelista W,
Fanchini L, et al: Gruppo oncologico nord ovest: Phase III trial of
infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan
(FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and
irinotecan (FOLFIRI) as first-line treatment for metastatic
colorectal cancer: The Gruppo Oncologico Nord Ovest. J Clin Oncol.
25:1670–1676. 2007. View Article : Google Scholar
|
|
55
|
Amin B, Poureshagh E and Hosseinzadeh H:
The effect of verbascoside in neuropathic pain induced by chronic
constriction injury in rats. Phytother Res. 30:128–135. 2016.
View Article : Google Scholar
|
|
56
|
Wang WG, Wang P and Yang ZQ:
Pharmacological effects of verbascoside: Research advances. J
Intern Pharm Res. 47:1078–1087. 2020.In Chinese.
|
|
57
|
Chen M, Nowak DG and Trotman LC: Molecular
pathways: PI3K pathway phosphatases as biomarkers for cancer
prognosis and therapy. Clin Cancer Res. 20:3057–3063. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Yuen JW, Chung GT, Lun SW, Cheung CC, To
KF and Lo KW: Epigenetic inactivation of inositol polyphosphate
4-phosphatase B (INPP4B), a regulator of PI3K/AKT signaling pathway
in EBV-associated nasopharyngeal carcinoma. PLoS One.
9:e1051632014. View Article : Google Scholar
|
|
59
|
Chen T, Xue H, Lin R and Huang Z: MiR-126
impairs the intestinal barrier function via inhibiting S1PR2
mediated activation of PI3K/AKT signaling pathway. Biochem Biophys
Res Commun. 494:427–432. 2017. View Article : Google Scholar
|
|
60
|
Zhuang B, Zhang J, Sun TQ, et al:
Aflibercept alleviates high glucose-induced retinal pigment
epithelial cell injury and PI3K/AKT signaling pathway activation.
Chin J Histochem Cytochem. 30:235–239. 2021.In Chinese.
|
|
61
|
Ren BY: Correlation of INPP4B gene on
proliferation, metastasis and apoptosis of ovarian cancer cells.
Dalian Medical University; 2018
|
|
62
|
Yao JG: Expression and significance of
SOX2 and CyclinD1 in epithelial ovarian carcinoma. Zhengzhou
University; 2014
|
|
63
|
Zhang L, Zeng D, Chen Y, Li N, Lv Y, Li Y,
Xu X and Xu G: miR-937 contributes to the lung cancer cell
proliferation by targeting INPP4B. Life Sci. 155:110–115. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Tang W, Yang L, Yang T, Liu M, Zhou Y, Lin
J, Wang K and Ding C: INPP4B inhibits cell proliferation, invasion
and chemoresistance in human hepatocellular carcinoma. Onco Targets
Ther. 12:3491–3507. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Tang QF, Sun J and Yu H: Research progress
on antitumor multidrug resistance of traditional Chin medicine
based on PI3K/AKT signaling pathway. J Shanghai Univ Trad Chin Med.
30:78–82. 2016.In Chinese.
|
|
66
|
Bamodu OA, Chang HL, Ong JR, Lee WH, Yeh
CT and Tsai JT: Elevated PDK1 expression drives PI3K/AKT/MTOR
signaling promotes radiation-resistant and dedifferentiated
phenotype of hepatocellular carcinoma. Cells. 9:7462020. View Article : Google Scholar :
|
|
67
|
Yang L, Zhang B, Liu J, Dong Y, Li Y, Li
N, Zhao X, Snooks H, Hu C and Ma X: Protective effect of acteoside
on ovariectomy-induced bone loss in mice. Int J Mol Sci.
20:29742019. View Article : Google Scholar
|
|
68
|
Attia YM, El-Kersh DM, Wagdy HA and
Elmazar MM: Verbascoside: Identification, quantification, and
potential sensitization of colorectal cancer cells to 5-FU by
targeting PI3K/AKT pathway. Sci Rep. 8:169392018. View Article : Google Scholar
|
|
69
|
Wen LM, Zhang JW and Chen Z: Study on
synergistic effect of acteoside combined with Ly294002 on
transplanted human hepatocellular carcinoma in nude mice. Chin J
Cancer Prev Treat. 30:904–911. 2023.In Chinese.
|
|
70
|
Xing HZ, Sang F and Duan XY: Study on
protective effect and mechanism of gallotannin on IFN-γ-induced
Caco-2 cell monolayer barrier damage. J Chin Med Mater.
44:2663–2668. 2021.In Chinese.
|
|
71
|
Xia LM, Yu H and Jin Z: Mechanism of
PI3K/AKT mediated platelet apoptosis via mitochondrial pathway in
thrombocytopenia in immune bone marrow failure. J Henan Univ (Med
Sci). 41:263–267+271. 2022.In Chinese.
|
|
72
|
Chen X: The role and molecular mechanism
of PI3K/Akt signaling pathway in megakaryocyte/platelet-mediated
pathological process. Shanghai Jiaotong University; 2014
|
|
73
|
Niu YB, Wang XL and Chen C: Effect of
inhibition of PI3K-AKT-mTOR signaling pathway by metformin on acute
liver injury induced by carbon tetrachloride in mice. Chin J Biol.
34:1062–1068+1075. 2021.In Chinese.
|
|
74
|
Leng J: The protective effects of saponins
from platycodi radix on cisplatin-induced nephrotoxicity via NF-κB
and PI3K/AKT signaling pathway. Jilin Agricultural University;
2019
|
|
75
|
Jiang S, Yang SQ and Zhou B: Lycopene
protects kidney against nonylphenol-induced nephrotoxicity by
regulating PI3K/Akt/p53 pathway. Chin J Vet Sci. 42:973–980.
2022.In Chinese.
|
|
76
|
Zhang DD, Gu QY and You QX: Effects of
hydrogen sulfide in paraventricular nuclei on blood pressure,
peripheral sympathetic nerve activity and PI3K/Akt pathway in high
salt-induced hypertensive rats. Chin J Tissue Engineer Res. 27:1–7.
2023.In Chinese.
|
|
77
|
Xu LJ, Wang J, Li YD, Shen KF, He XH, Wu W
and Liu CC: Reduction of SIRT1-mediated epigenetic upregulation of
Nav1.7 contributes to oxaliplatin-induced neuropathic pain. Pain
Physician. 26:E213–E222. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Ma J, Long LH, Hu ZL, Zhang H, Han J, Ni
L, Wang F, Chen JG and Wu PF: Activation of D1-like
receptor-dependent phosphatidylinositol signal pathway by SKF83959
inhibits voltage-gated sodium channels in cultured striatal
neurons. Brain Res. 1615:71–79. 2015. View Article : Google Scholar : PubMed/NCBI
|
